Laplace Interventional
Latest round
- Series C
Last raised
- Mar 2025
Total raised
- $42M
Investors
- 7
About Laplace Interventional
, operates as a developer and provider of minimally invasive transcatheter treatment for patients suffering from Tricuspid Regurgitation. In March 2025, Laplace Interventional, Inc. The company offers a prosthetic transcatheter valve that is used for the treatment of tricuspid regurgitation. The company uses transcatheter tricuspid valve technology to increase the life expectancy of patients suffering from tricuspid regurgitation (TR).
Who invested in Laplace Interventional
7 investors across 3 rounds
See all investors in Laplace Interventional
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Laplace Interventional
Who invested in Laplace Interventional?
Laplace Interventional has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Laplace Interventional raised?
Laplace Interventional has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Laplace Interventional last raise money?
Laplace Interventional's most recent round on record is a Series C, in Mar 2025.
What does Laplace Interventional do?
, operates as a developer and provider of minimally invasive transcatheter treatment for patients suffering from Tricuspid Regurgitation.
Where is Laplace Interventional headquartered?
Laplace Interventional is headquartered in Plymouth, US.
Which VCs invest in companies like Laplace Interventional?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Laplace Interventional's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Laplace Interventional? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.